What's Blocking Your Innovation?
??Dr Roxie Mooney, DBA
?? I help healthtech founders fast-track to their first million. ?? Healthtech Startup Growth Coach | GTM Strategist | Board Director | Fractional CMO ???? ???? ???? ???? ?????????? ????????
Move Innovation Mountains with the Commercialization Imperative
Dr. Roxie here ready to rock you again with more healthcare innovation insights. Today, we're talking about a challenge that's got us all singing, "Ain't no mountain high enough" – the adoption problem.
Now, listen up, because this is a real head-scratcher. Can you believe that 95% of health innovations still fail to gain traction? I know, it's mind-blowing! We've got funding, we've got ideas, but something's holding us back.?
And that something is a lack of adoption, my friends.
But fear not! We're taking adoption and diving headfirst into the Commercialization Imperative because, let's face it, we can't afford to keep pouring trillions of dollars into ideas that end up in the dreaded zombie graveyard, where great ideas go to die.?
Get the scoop on how the Commercialization Imperative can be like CPR for innovations [Link]
Here's the deal: successful implementation doesn't automatically lead to successful adoption. Nope, it's just the beginning of a wild roller coaster ride. To truly make an impact, we need a strategic and comprehensive approach to driving adoption. Without it, even the most groundbreaking innovations will be left gathering dust.
So, let's get real and address the elephant in the room. We need to learn from our failures and understand the common pitfalls that trip up even the most innovative minds. Take a look at the cautionary tales of Pear Therapeutics, Haven, Microsoft HealthVault, and Google Health. They represent seemingly great ideas -- from powerful brands -- that suffered from 'failure to adopt.' These lost legends remind us that we've got work to do. That work begins with the letter A: for adoption.
Now, brace yourselves because it's time to start climbing.
领英推荐
Commercialization know-how is the secret sauce that many overlook. We've seen the rise of healthcare incubators, accelerators and innovation hubs, but success rates are still stuck in a rut.?
Because product adoption isn’t a passive event. It’s a proactively driven strategic outcome. We’ve got to plan for it, starting with that first 16% of the Diffusion of Innovation curve -- the innovators and . It's time to bridge the gap and arm our innovators, buyers, and builders with the strategies and insights necessary to drive adoption and grab that first 16%, so mainstream acceptance follows. We do that with the Commercialization Imperative.
But wait, there's more! We're not just here to chat; we're here to take action. Together, let’s explore the challenges and unveil actionable best practices to break down those adoption barriers. They are the lifeblood of the Commercialization Imperative. No more waiting around for change – it's time to make things happen.
Imagine the possibilities! We're talking about saving billions of dollars and thousands of hours lost to 'failures to launch.' More importantly, we're talking about driving innovation, improving patient outcomes and, dare I say it, saving lives!
So, my fellow healthcare warriors, let's talk about the Commercialization Imperative.
Let's challenge ourselves to summit the mountain we know as the adoption gap and ensure the success of those mind-blowing breakthrough technologies. Lives are counting on us, and we're ready to deliver.
DM me with “Commercialization Imperative”and I'll tell you more.
Keep innovating, keep pushing boundaries, keep moving mountains. Let's show the world what innovators are made of.
Let's rock on!
Translating scientific knowledge into applications and building businesses
1 年Thanks for a great article ??Dr Roxie Mooney, DBA I always enjoy hearing your ideas. I've got a question - isn't it possible that the failure to gain adoption is also a mechanism for differentiating the truly great ideas from the impractical or mediocre ones? Maybe not every "great" idea needs to or deserves to survive. I agree that the Chasm is excessively brutal in killing off worthwhile business concepts, but it also serves a culling function in the same way that a shepherd might cull their flock or the brain kills off excessive connections between specific regions ("pruning"). On a related topic, I have heard an argument against technology incubators that they sometimes allow non-viable businesses to survive on life support without a future prognosis for survival, because they are missing something critical. How would you differentiate between useful culling while at the same time allowing a greater percentage of early stage worthwhile ventures to survive? Thanks!
President at ISeeYouCare, Inc.
1 年Dr. Mooney, It's funny that you mentioned Microsoft's HealthVault. ISeeYouCare took that idea back in 2009 and took it to where Microsoft never could with a Personal Health Records based solution (cloud and mobile). The solution was one of three enterprise system of the first Telemedicine-based EHR in North America which launched in 2010. This consumer/patient solution could agnostically pull a persons medical history from every Certified EHR in North America (to include the VA and DOD Systems) without being wired to the EHR or even with the consent of the Health System. The data was then parsed, normalized and consolidated into one longitudinal medical history with the ability to share it with any provider in five ways. Then we developed a Smart Health benefits card that was scored by the GAO as having the ability of cutting the cost of healthcare for a Medicare population demographic by $2018 per patient per year or $116 Billion a year in savings to CMS. That same GAO study that ONB reviewed which prompted the meeting in Washington in 2018 stated that if this technology was adopted by the US on a National Scale, it would reduce the cost of healthcare by some $1.1 Trillion a year! It's all about the money!